Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
NCT05759897Phase 2Unknown
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Feb 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of HRS-7535 in type 2 diabetes mellitus (T2DM), sponsored by Shandong Suncadia Medicine Co., Ltd.. Status: unknown.
02
Drugs
HRS-7535
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05759897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05759897.